ACUTE-Acute Surgical Care- Risk Factors and Outcomes for Patients in Need of Acute Surgical Care
NCT ID: NCT05195697
Last Updated: 2023-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2020-01-01
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mild Hypothermia Influence on Patient Outcome in Major Abdominal Surgery
NCT03112317
Is Peri-operative Hyperoxemia a Risk Factor for Postoperative Complications?
NCT02562781
Predictors, Risk Factors and Outcome Following Major Surgery
NCT02626546
Risk Stratification for Abdominal Emergency Surgery: a Cohort Study
NCT06501170
Perioperative Risk Factors of Outcomes for Cardiac Surgery: A Retrospective Study
NCT04980742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Assessment instruments for risks and frailty are not validated for the acute setting and the investigators hypothesize there is room for improvement in prophylactic interventions and risk assessment. The investigators will study cohorts of patients with three different surgical diagnosis: acute pancreatitis, gastrointestinal bleeding and perforated ulcer aiming to identify risk factors for complications or death and to investigate assessment tools in this population. Using propensity score analysis, the investigators will try to identify treatment options associated with better outcome for subcohorts defined by frailty, comorbidity, age or gender. Specific factors of interest include: time to- and kind of treatment, handling of ongoing pharmacological therapy (anticoagulants, corticosteroids) and need for further treatments on a long time basis. The results from this project will be used in a future prospective study where prophylactic treatments and specific treatment options are studied.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mild acute pancreatitis
Patients treated with mild acute pancreatitis during the study period
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Moderate acute pancreatitis
Patients treated with moderate acute pancreatitis during the study period
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Severe acute pancreatitis
Patients treated with severe acute pancreatitis during the study period
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Acute gastrointestinal bleeding
Patients treated with acute gastrointestinal bleeding during the study period
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Perforated ulcer
Patients treated with perforated ulcer during the study period
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Older than 70 years
Patients older than 70 years
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Less than 70 years
Patients younger than 70 years
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Prothrombotic medications
Patients on prothrombotic medications
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Frail patients
Patients with increased frailty score
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Reintervention group
Patients in need of reintervention
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational study of different treatments and time to treatment
Different treatment based on the clinical decision
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sara Regnér, PhD
Role: PRINCIPAL_INVESTIGATOR
Region Skåne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Skåne University Hospital
Malmo, Skåne County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Forsberg-Puckett A, Wurm Johansson G, Regner S. Presentation of gastrointestinal bleeding in patients with antithrombotic therapy, results from a consecutive retrospective cohort. Scand J Trauma Resusc Emerg Med. 2025 Sep 10;33(1):146. doi: 10.1186/s13049-025-01431-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-03583
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.